Nanosonics Limited ( NNCSF) - Key Metrics
NNCSF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0.34 | $0.03 | $0.05 | $0.04 |
| 2026Q2 | $0.34 | $0.03 | $0.02 | $0.01 |
| 2025Q4 | $0.35 | $0.04 | $0.08 | $0.07 |
| 2025Q2 | $0.30 | $0.03 | $0.07 | $0.05 |
| 2024Q4 | $0.29 | $0.02 | $0.04 | $0.04 |
NNCSF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | 33.99 |
| 2026Q2 | 0% | 34.15 |
| 2025Q4 | 0% | 24.80 |
| 2025Q2 | 0% | 26.34 |
| 2024Q4 | 0% | 22.52 |
NNCSF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | 1.18% | 0% |
| 2026Q2 | 0.33% | 0% |
| 2025Q4 | 1.85% | 0% |
| 2025Q2 | 1.45% | 0% |
| 2024Q4 | 1.39% | 0% |
NNCSF
Price: $1.84
52 week price:
Earnings Per Share: 0.04 USD
P/E Ratio: 48.50
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 608.6 million